STERIS EBITDA 2010-2024 | STE
STERIS annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- STERIS EBITDA for the quarter ending September 30, 2024 was $0.335B, a 2.58% decline year-over-year.
- STERIS EBITDA for the twelve months ending September 30, 2024 was $1.360B, a 28.57% decline year-over-year.
- STERIS 2024 annual EBITDA was $1.406B, a 23.66% decline from 2023.
- STERIS 2023 annual EBITDA was $1.842B, a 67.82% increase from 2022.
- STERIS 2022 annual EBITDA was $1.098B, a 42.99% increase from 2021.
| STERIS Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $1,406 |
| 2023 | $1,842 |
| 2022 | $1,098 |
| 2021 | $768 |
| 2020 | $734 |
| 2019 | $637 |
| 2018 | $578 |
| 2017 | $473 |
| 2016 | $357 |
| 2015 | $319 |
| 2014 | $282 |
| 2013 | $312 |
| 2012 | $285 |
| 2011 | $140 |
| 2010 | $260 |
| 2009 | $238 |
| STERIS Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-09-30 | $335 |
| 2024-06-30 | $298 |
| 2024-03-31 | $365 |
| 2023-12-31 | $362 |
| 2023-09-30 | $344 |
| 2023-06-30 | $336 |
| 2023-03-31 | $895 |
| 2022-12-31 | $329 |
| 2022-09-30 | $321 |
| 2022-06-30 | $297 |
| 2022-03-31 | $358 |
| 2021-12-31 | $322 |
| 2021-09-30 | $320 |
| 2021-06-30 | $98 |
| 2021-03-31 | $203 |
| 2020-12-31 | $204 |
| 2020-09-30 | $196 |
| 2020-06-30 | $165 |
| 2020-03-31 | $209 |
| 2019-12-31 | $192 |
| 2019-09-30 | $176 |
| 2019-06-30 | $157 |
| 2019-03-31 | $191 |
| 2018-12-31 | $152 |
| 2018-09-30 | $153 |
| 2018-06-30 | $141 |
| 2018-03-31 | $157 |
| 2017-12-31 | $148 |
| 2017-09-30 | $144 |
| 2017-06-30 | $129 |
| 2017-03-31 | $110 |
| 2016-12-31 | $116 |
| 2016-09-30 | $120 |
| 2016-06-30 | $127 |
| 2016-03-31 | $152 |
| 2015-12-31 | $92 |
| 2015-09-30 | $46 |
| 2015-06-30 | $67 |
| 2015-03-31 | $90 |
| 2014-12-31 | $83 |
| 2014-09-30 | $81 |
| 2014-06-30 | $65 |
| 2014-03-31 | $80 |
| 2013-12-31 | $75 |
| 2013-09-30 | $68 |
| 2013-06-30 | $59 |
| 2013-03-31 | $86 |
| 2012-12-31 | $85 |
| 2012-09-30 | $78 |
| 2012-06-30 | $63 |
| 2012-03-31 | $91 |
| 2011-12-31 | $70 |
| 2011-09-30 | $63 |
| 2011-06-30 | $61 |
| 2011-03-31 | $72 |
| 2010-12-31 | $49 |
| 2010-09-30 | $68 |
| 2010-06-30 | $-50 |
| 2010-03-31 | $66 |
| 2009-12-31 | $74 |
| 2009-09-30 | $64 |
| 2009-06-30 | $57 |
| 2009-03-31 | $63 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $20.308B | $5.139B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $207.434B | 25.31 |
| Intuitive Surgical (ISRG) | United States | $194.997B | 101.95 |
| Edwards Lifesciences (EW) | United States | $43.303B | 27.50 |
| Alcon (ALC) | Switzerland | $41.141B | 27.53 |
| IQVIA Holdings (IQV) | United States | $36.894B | 20.33 |
| IDEXX Laboratories (IDXX) | United States | $34.232B | 40.31 |
| DexCom (DXCM) | United States | $30.373B | 45.74 |
| Waters (WAT) | United States | $22.584B | 33.39 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.662B | 0.00 |
| Hologic (HOLX) | United States | $16.272B | 17.57 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.198B | 13.55 |
| Globus Medical (GMED) | United States | $11.856B | 30.02 |
| Sysmex ADR (SSMXY) | Japan | $11.516B | 36.11 |
| Penumbra (PEN) | United States | $9.619B | 94.22 |
| Masimo (MASI) | United States | $8.910B | 43.11 |
| Glaukos (GKOS) | United States | $8.631B | 0.00 |
| Teleflex (TFX) | United States | $8.110B | 12.93 |
| Inari Medical (NARI) | United States | $4.642B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.532B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.486B | 25.42 |
| Veracyte (VCYT) | United States | $3.219B | 96.60 |
| LivaNova (LIVN) | United Kingdom | $2.534B | 14.63 |
| Nihon Kohden (NHNKY) | Japan | $2.370B | 18.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.364B | 0.00 |
| TransMedics (TMDX) | United States | $2.309B | 73.20 |
| Elekta AB (EKTAY) | Sweden | $2.138B | 19.22 |
| Integra LifeSciences Holdings (IART) | United States | $1.683B | 8.79 |
| Alphatec Holdings (ATEC) | United States | $1.414B | 0.00 |
| RxSight (RXST) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.253B | 83.00 |
| Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.867B | 0.00 |
| AxoGen (AXGN) | United States | $0.794B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.730B | 17.21 |
| IRadimed (IRMD) | United States | $0.717B | 38.76 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.699B | 11.88 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.650B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.592B | 0.00 |
| SiBone (SIBN) | United States | $0.575B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.575B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.498B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.476B | 25.05 |
| Treace Medical Concepts (TMCI) | United States | $0.455B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.413B | 22.38 |
| ClearPoint Neuro (CLPT) | United States | $0.405B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.367B | 0.00 |
| NeuroPace (NPCE) | United States | $0.356B | 0.00 |
| CVRx (CVRX) | United States | $0.344B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.226B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.216B | 0.00 |
| Accuray (ARAY) | United States | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.165B | 0.00 |
| Nevro (NVRO) | United States | $0.123B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.114B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.111B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 11.47 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| 908 Devices (MASS) | United States | $0.079B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| Hyperfine (HYPR) | United States | $0.069B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.061B | 31.57 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.057B | 0.00 |
| Neuronetics (STIM) | United States | $0.052B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.044B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.039B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.009B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |